ðºèŠçŽïœãåœé£ãèªç¥çãéèŠèª²é¡ãžïŒãNCDãã«å ããæå³ãšãç§ãã¡ã®æªæ¥

2025幎9æ25æ¥ãåœéã¢ã«ããã€ããŒç åäŒïŒADIïŒã¯ãåœé£ç·äŒãµã€ãã€ãã³ãã«ãããŠãåœé£å çåœãNCDïŒéææççŸæ£ïŒã®é ç®ã«èªç¥çãå«ããããšãå ±åããŸããã
ããããŠããµã€ãã€ãã³ãã®åç»ãå ¬éããŸãããããã§ã¯ãã®åç»ã®å 容ãèŠçŽããŠãäŒãããŸãã
宣èšãåããŠã®AIDã³ã¡ã³ãèšäºã¯ãã¡ãïŒ
ïŒïŒïŒïŒ
èªç¥çã®éæææ§çŸæ£ïŒNCDsïŒå®£èšãžã®çµã¿å ¥ããšå®æœãžã®éç
åç»
1. ãªãŒããã³ã°ãšæŽå²ç転æç¹ïŒç¥è³ããè¡åãž
1.1. ã€ãã³ãã®èæ¯ãšåã³ã®è¡šæ
æ¬ã€ãã³ãã¯ãADIïŒåœéã¢ã«ããã€ããŒç åäŒïŒãWHOïŒäžçä¿å¥æ©é¢ïŒãšå ±å¬ããMary Oakley財å£ããã³Dian and D Richard財å£ã®æ¯æŽãåããŠéå¬ãããŸããã
åœåã¯ãèªç¥çã«é¢ããè¡ååèµ·ïŒCall to ActionïŒã®å Žãšãªãäºå®ã§ããããéå¬çŽåã«èªç¥çãåœé£ã®éæææ§çŸæ£ïŒNCDsïŒå®£èšã«æ£åŒã«å«ããããããšã決å®ïŒæšææ¥ã«å ¬åŒåïŒãããããã€ãã³ãã®ããŒã³ã¯äžå€ãã**ãç¥è³ãšåã³ã**ã®æ©äŒãšãªããŸããã
ãã®æŽå²çãªææã¯ãWHOã®è²¢ç®ã«ãæ·±ãæè¬ãããŠããŸããããã«ãããã€ãã³ãã®çŠç¹ã¯ã次ã«äœãèµ·ããããã宣èšã®å®æœãšå®è¡ãžã®éçããžãšç§»è¡ããŸããã
ADIã¯1984幎ã«èšç«ãããäžçäžã®105ã®ã¢ã«ããã€ããŒç åäŒãæããé£åäœã§ãããã®ããžã§ã³ã¯ããäºé²ãã±ã¢ãã€ã³ã¯ã«ãŒãžã§ã³ã仿¥ã«ããããŠææ¥ã®æ²»çæ³ãæåŸ ããããšãããã®ã§ãã
1.2. èªç¥çã®å¯èŠåïŒNCDs宣èšçµã¿å ¥ãã®æçŸ©
é·å¹Žã«ããããèªç¥çã¯éæææ§çŸæ£ïŒNCDsïŒã®æŠå¿µã«ã¯å«ãŸããŠããªããããäž»èŠãªNCDsã®äžã€ãšããŠå ¬åŒãªå®£èšããé€å€ãããŠããŸããããã®èæ¯ã«ã¯ã**ã¹ãã£ã°ãïŒåèŠïŒ**ãååšãããã®çµæãšããŠãèªç¥çã¯ååœã®ä¿å¥èšç»ããã©ãããã©ãŒã ãäºç®ãæŠç¥ããæãèœã¡ãŠããŸããšããæªåŸªç°ããããŸããã
ãã®ç¶æ³ãä»å¹Žããæ±ºå®çã«å€ããã€ã€ãããŸããNCDs宣èšãžã®çµã¿å ¥ããå®çŸããããšã§ãä»åŸã®ç¬¬äžæ©ã¯ãNCDsã®äºé²ãšç®¡çã«é¢ããã°ããŒãã«ãªè°è«ã«ãããŠãèªç¥çã®å¯èŠæ§ãå€§å¹ ã«é«ããããšã§ãããããŸã§ã¯ãADIã¡ã³ããŒãååœã®ä¿å¥çãšNCDsã«ã€ããŠåè°ããéã**ãèªç¥çã¯NCDã§ã¯ãªãã**ãšããŠããªã¹ã¯è»œæžã®ããã®ãã£ã³ããŒã³ã«åå ã§ããªãã±ãŒã¹ãå€çºããŠããŸããã
ãã®å€åãåŸæŒãããã®ã¯ãADIãªã©ãä»å¹Žããã€ãã£ãŒã»ã¬ãã¥ãŒã»ãã¥ãŒãããžãŒãã«çºè¡šããè«æã§ãããã®è«æã¯ãçŸåšã®åŸåãç¶ãã°ãèªç¥çã2040幎ãŸã§ã«äžççã«èŠãŠæ»å ã®ç¬¬3äœãšãªãã166ã«åœã§æ»å ã®ããã10ã«å ¥ããšäºæž¬ããŸããããã®äºæž¬ã¯ãèªç¥çãåãªããé«éœ¢åã®èªç¶ãªçµæãã§ã¯ãªããå ¬è¡è¡çäžã®**ãäž»èŠãªå±æ©ã**ãšããŠèªèãããæ±ºå®æãšãªããŸããã
2. äžççãªèª²é¡ãšWHOã®è¡åèšç»
2.1. 屿©çãªçŸç¶ãšã°ããŒãã«ãªèª²é¡
WHOã¯ããã®åé¡ã«å¯ŸããŠãã倧ããªè¡åãæè³ã泚ç®ãå¯èŠåãå¿ èŠã§ãããšåŒ·ã蚎ããŠããŸããçŸåšãäžçã®èªç¥çæ£è æ°ã¯æšå®5,700äžäººã§ããããã®æ°ã¯2030幎ã«çŽ7,800äžäººã«ããããŠ2050幎ãŸã§ã«ã¯ããã«åå¢ãããšäºæž¬ãããŠããŸãã
ãã®å£æ» çãªæªæ¥äºæž¬ã«å¯Ÿããäžçã¯çŸç¶ã**ãæ·±ãæºåäžè¶³ïŒdeeply unpreparedïŒã**ã§ãããšèªèãããŠããŸããããããäœããã¹ããããã®éçã¯æ¢ã«åãã£ãŠããŸãã
WHOå çåœã¯ãèªç¥çãžã®å ¬è¡è¡ç察å¿ã«é¢ããã°ããŒãã«è¡åèšç»ã2031幎ãŸã§å»¶é·ããããšã«åæããŠããããã®åé¡ã«å¯ŸããåŒ·ãæ¿æ²»çã³ãããã¡ã³ãã瀺ãããŠããŸãã
2.2. èªç¥çãªã¹ã¯åæžã®ãWin-Winã®ç¶æ³ã
æŠç¥çè¡åã®æ žãšãªãã®ã¯ãèªç¥çã®ãªã¹ã¯åæžã§ããç§åŠç蚌æ ã«åºã¥ããèªç¥çã®çäŸã®40%ã¯ããªã¹ã¯å åãžã®é©åãªå¯ŸåŠã«ããçºçãé å»¶ãŸãã¯åæžã§ããå¯èœæ§ããããšãããŠããŸãã
ç¹çãã¹ãã¯ãéæææ§çŸæ£ïŒNCDsïŒã®äž»èŠãªãªã¹ã¯å åãšãèªç¥çã®ãªã¹ã¯å åã¯åäžã§ãããšããäºå®ã§ããå ·äœçã«ã¯ãé«è¡å§ãç³å°¿ç ãéåäžè¶³ãå«ç ãè¥æºãªã©ãå ±éã®ãªã¹ã¯å åã§ãã
ãã®å ±éæ§ããã**ãwin-winã®ç¶æ³ããçã¿åºããŸããã€ãŸãããµã€ãåããåãçµã¿ããè±åŽããããçžä¹çïŒsynergisticallyïŒ**ã«é£æºããã°ãä»ã®NCDsïŒçãå¿è¡ç®¡çŸæ£ãªã©ïŒã®äºé²ã»ç®¡çã®æ¹åã¯ãèªç¥æ©èœé害ãèªç¥çã®æ¹åã«ã€ãªããããã®éãæç«ããŸãã
ãããçŸç¶ãšããŠãèªç¥çãªã¹ã¯åæžã®ããã®ã¬ã€ãã©ã€ã³ããã£ã³ããŒã³ãæã€åœã®å²åã¯ååæªæºã§ããããã®å€ãã髿åŸåœã«éäžããŠããŸãããã®ã®ã£ãããåããããšããä»åŸã®å€§ããªèª²é¡ãšãªããŸãã
3. ããã«ãã£ã¹ã«ãã·ã§ã³ïŒååœã®å ·äœçãªå®æœæŠç¥
NCDs宣èšãžã®çµã¿å ¥ããšãã倧ããªäžæ©ãèžã¿åºããä»ãããã«ãã£ã¹ã«ãã·ã§ã³ã§ã¯ãæ¿åºãNGOãå人ã¬ãã«ã§æ¬¡ã«äœãè¡ããã©ã®ããã«å®è¡ã»å®è£ ã§ãããã«ã€ããŠãååœã®ä»£è¡šè ããå ·äœçãªèŠç¹ãå ±æãããŸããã
3.1. ã€ã³ããã·ã¢ïŒå€§èŠæš¡ã¹ã¯ãªãŒãã³ã°ãšã€ã³ãã©æŽå
ããã£ã»ãµãã£ãã³ä¿å¥å€§è£ã¯ã矩æ¯ã®ã¢ã«ããã€ããŒç ã®çµéšãããã®åé¡ã®æ·±å»ããå人çã«çè§£ããŠãããšè¿°ã¹ãŸãããã€ã³ããã·ã¢ã¯è¥å¹Žå±€ãå€ãåœã§ãããé«éœ¢åãžã®åããšããŠä»¥äžã®ç»æçãªåãçµã¿ãé²ããŠããŸãã
- 蚺æã€ã³ãã©ãžã®å€§èŠæš¡æè³ïŒäžçéè¡ããã®èè³ãåããèªç¥ç蚺æã«äžå¯æ¬ ãªPETã¹ãã£ã³ã®æ°ãåçã«å¢å ãããèšç»ã§ãã2020幎12æã«ã¯åœå ã«1å°ãããªãã£ãPETã¹ãã£ã³ãã2027幎æ«ãŸã§ã«16å°ãããã«PET-CTã14å°ããµã€ã¯ãããã³ãçŽ10å°ã«å¢ãããèšºææ©èœã匷åããŸãã
- 矩åçãªå¹Žéã¹ã¯ãªãŒãã³ã°ïŒä»å¹Ž2æã«ã2å8000äžäººã®åœæ°ã察象ãšãã矩åçãªå¹Žéã¹ã¯ãªãŒãã³ã°ããã°ã©ã ãç«ã¡äžããŸããããã®ããã°ã©ã ã«ã¯ãé«éœ¢è åãã®èªç¥çã¹ã¯ãªãŒãã³ã°è³ªå祚ãå«ãŸããŠãããæ©æçºèŠãç®æããŸãã
- ãªã¹ã¯å åã®çµ±å管çïŒèªç¥çãšå¿è¡ç®¡çŸæ£ã«å ±éãã14ã®ãªã¹ã¯å åïŒé«è¡å§ãç³å°¿ç ãéåäžè¶³ãè¥æºãªã©ïŒãç¹å®ããã¹ã¯ãªãŒãã³ã°ææšã«å«ããŠããŸããçµæã¯è²åãïŒèµ€ãé»ãç·ïŒã§åãããããéç¥ãããåœæ°ã«äºé²è¡åãä¿ããŸãã
- å®¶æä»è·è ãžã®æ¯æŽïŒä»è·è ã®ç²Ÿç¥çè² æ ãèªèããå®¶æä»è·è åãã®ã¹ãã«ãå¿èãããŒã«ãæäŸããããã®ç ä¿®ããã°ã©ã ãåµèšããæåã瀺ããŸããã
3.2. ãªã©ã³ãïŒåœå®¶æŠç¥ãšãžã§ã³ããŒå¹³çã®èŠç¹
ãžã¥ãã£ã»ã¿ã³éå°å¹Žäºé²ã¹ããŒã倧è£ã¯ããªã©ã³ãã«ãããèªç¥çãå»çè²»ã®æå€§ã®è² æ ãšãªã£ãŠãããå»çã·ã¹ãã ãšå»çåŸäºè ã«ç倧ãªåœ±é¿ãäžããŠããçŸç¶ãå ±åããŸããã
- äºé²ã®å¯èœæ§ïŒãªã©ã³ãã§ãã**æå€§45%**ã®èªç¥çã±ãŒã¹ããNCDsãšå ±éãããªã¹ã¯å åãžã®å¯ŸåŠã«ããäºé²ãŸãã¯é å»¶ã§ãããšåŒ·èª¿ããŸããã
- åœå®¶èªç¥çæŠç¥ïŒ2021幎ãã2030幎ãŸã§å®æœãããŠãããã®æŠç¥ã¯ã以äžã®3ã€ã®æ±ã«åºã¥ããŠããŸãã
- ç§åŠç ç©¶ã«ããèªç¥çã®æ ¹çµ¶ã
- èªç¥çã®äººã ã«å¯Ÿãã瀟äŒã®è¯å®çæ 床ã®ä¿é²ã
- èªç¥çæ£è ïŒç¹ã«èªå® ã§æ®ããåææ®µéã®71%ã®äººã ïŒãšãã®æãã人ãžã®åå¥åãããæ¯æŽã
- ãžã§ã³ããŒã®èŠç¹ïŒèªç¥çã¯å¥³æ§ã«ãã倧ããªåœ±é¿ãäžããŸãããªã©ã³ãã§ã¯æ£è ã®3åã®2ã女æ§ã§ãããããã«ä»è·è ã®70%ã女æ§ã§ããããã女æ§ã¯äºéã®è² æ ãè² ã£ãŠããŸãããŸãã女æ§ã¯ç ç©¶ã«ããã代衚æ§ãäœããèªç¥çã女æ§ã«ãããŠé²è¡ãéããèªèãé£ãã圢ã§çŸããå¯èœæ§ããããããæŠç¥ã®æåã«ã¯å¥³æ§ã®å¥åº·ãè°è«ã®äžå¿ã«çœ®ãå¿ èŠããããšåŒ·èª¿ããŸããã
3.3. ãã©ãžã«ïŒæ¥éãªé«éœ¢åãšæ¿çã®èª²é¡
ãã«ã»ã¢ã³ãžã§ã©ã»ããã£ã¹ã¿ã»ã¬ã«ãã³ä¿å¥å¯å€§è£ã¯ããã©ãžã«ããã©ãªã¢ãªã©ã®èª²é¡ãæ±ãã€ã€ãæ¥éãª**人å£åæ ã®ç§»è¡ïŒé«éœ¢åïŒ**ã«çŽé¢ããŠããããšã説æããŸããã
- çŸç¶ïŒ2024幎ã®å šåœã¬ããŒãã«ãããšããã©ãžã«åœå ã®èªç¥çæç çã¯æšå®200äžäººã§ãããæ¯å¹Ž30äžä»¶ã®æ°èŠçäŸã蚺æãããŠããŸãã
- æ¿çã®æ¬ ç¹ïŒãã©ãžã«ã¯ãŠãããŒãµã«ãã«ã¹ã·ã¹ãã ïŒSUSïŒãæããç¥çµçŸæ£ãæã€äººã ãžã®åœå®¶çãªå¯Ÿå¿æ¿çãååšããŸãããäºé²ã®èŠçŽ ãæ¬ ããŠããããšãæå€§ã®æ¬ ç¹ã§ãããšææããŸããã
- 課é¡ïŒèšºæããã人ã ãå¿ èŠãªã±ã¢ãåããããããã«ããããšããããŠ**瀟äŒçä¿è·ïŒãœãŒã·ã£ã«ã»ãããã¯ã·ã§ã³ïŒãå«ãã»ã¯ã¿ãŒæšªæçãªåãçµã¿ïŒintersectoralityïŒ**ã®æ¹åããä»åŸã®äž»èŠãªèª²é¡ã§ãããšè¿°ã¹ãŸããã
3.4. ã³ã¹ã¿ãªã«ïŒããªãã«ã»ã¯ã©ã€ã·ã¹ãšå ¬å¹³æ§ãžã®æžå¿µ
ããªã¿ã»ãã£ã³ãåœé£åžžé§ä»£è¡šã¯ãã³ã¹ã¿ãªã«ãå°ããªåœãªãããæ®éçãªç€ŸäŒã·ã¹ãã ãç¯ããŠããæŽå²ã玹ä»ããŸããã
- é«éœ¢åã®é床ïŒçŸåš3äžäººã®èªç¥çæ£è ãããŸãããæ¥éãªé«éœ¢åã«ããã25幎åŸã«ã¯çäŸã400%æ¥å¢ãããšäºæ³ãããŠããŸãã
- ãããªãã«ã»ã¯ã©ã€ã·ã¹ãïŒæ£è ã®3åã®2ã女æ§ã§ãããšããäºå®ãããèªç¥çãå¥åº·å±æ©ãäººæš©å±æ©ã«å ããŠãžã§ã³ããŒå±æ©ã§ããããšæããã¹ãã ãšæèšããŸãããã·ã¹ãã ã«ãã£ãŠå¿ãããã女æ§ãã¡ãä»è·ã®å€ããæ ã£ãŠããç¶æ³ãå€ããå¿ èŠããããŸãã
- åœå®¶èšç»ãšç¥èŠã®å ±æïŒã³ã¹ã¿ãªã«ã¯2014幎ã«ã©ãã³ã¢ã¡ãªã«ã§åããŠ5ã幎èšç»ãæ¡æããäžæ¬¡å»çã§ã®æ©ææ€åºãã¡ã¢ãªãŒã¯ãªããã¯ã§ã®å®¶ææ¯æŽã宿œããŠããŸãã
- å ¬å¹³æ§ãžã®èšŽãïŒæ°ããæ²»çæ³ãæè¡ã¯åžæããããããŸããããè²»çšãè³ãã人ã ã«ããååšããªãããšããæžå¿µã匷ã瀺ããŸããããèŠããŠãã人ããšãå¿ããŠããŸã人ããããäºå±€ã®äžçãäœã£ãŠã¯ãªããªããšããäžæåŸåœãå«ãããã¹ãŠã®äººã ãä¿å¥ã«ã¢ã¯ã»ã¹ã§ãããããåœé瀟äŒã«çå£ãªå¯Ÿå¿ãæ±ããŸããã
3.5. èªç¥çåœäºè ïŒã¹ãã£ã°ãã®æ£åžžåãžã®æåŸ
èªç¥çåœäºè ã§ããã¬ãŽ. ã·ã³ã¹ã£ã¢ã»ããŒãã£ã³ã°ã¯ã蚺æãŸã§ã®å人çãªéã®ããå ±æããŸããã
- é·æã«ããã蚺æïŒ49æ³ã§çç¶ãçŸãå§ããŸããããæ£åŒãªèšºæãäžããŸã§ã«8幎éãèŠããŸãããå»åž«ããç§åž«ã®è·ãèŸããã瀺åãããåŸãæ®ãããæéãããã¶ããã£ãšïŒseven years, maybe moreïŒãã®ããã«çããããšã決æããŸããã
- åžæãžã®è»¢æïŒç¡åæãä¹ãè¶ãããããã¢ã«ããã€ããŒç åäŒã®ç ç©¶ïŒADNIïŒã«15幎éåå ããããªãç§ã«ïŒWhy meïŒããããæ¬¡ã¯äœãããïŒWhat’s nextïŒããžãšèŠç¹ã転æããŸããã
- NCDsçµã¿å ¥ãã®æçŸ©ïŒæ°è¬ãã©ã€ãã¹ã¿ã€ã«ä»å ¥ã«ããé å»¶ã®å¯èœæ§ãªã©ãä»ã¯åžæã«æºã¡ãæä»£ã§ãããšèªããŸããã圌女ã«ãšã£ãŠãèªç¥çãNCDs宣èšã«çµã¿å ¥ããããšã¯ãèªç¥çã®ã¹ãã£ã°ããæžããããæ£åžžåãããããã®äžççãªèª²é¡è§£æ±ºã®ãã³ã«ãªããšåŒ·èª¿ããŸãããããã«ãããå¿è¡ç®¡çŸæ£ãçãªã©ãšå調ããŠãªã¹ã¯åæžãã£ã³ããŒã³ãå±éããæ©äŒãçãŸããŸãã
4. ç§åŠãšã¢ããã«ã·ãŒã«ããå®è·µçãªåé²
4.1. ã¢ã«ããã€ããŒç åäŒCEOïŒç§åŠçæ ¹æ ãšå®è£ ç ç©¶
ãžã§ã³ã»ãã€ã¯CEOã¯ãèªç¥çã®NCDsçµã¿å ¥ãããç ç©¶ãæ²»çãã±ã¢ãé²å±ãããã®æŽå²çãªç¬éã«æ¥µããŠéèŠã§ãããšè¿°ã¹ãŸããã
- US POINTER詊éšã®çµæïŒãã£ã³ã©ã³ãã®FINGER詊éšã«åºã¥ããç±³åœã§ãªã¹ã¯åæžãæ€èšŒããUS POINTER詊éšã®ææ°çµæãå ±åããŸããããã®è©Šéšã¯ãæ é€ãèº«äœæŽ»åãèªç¥çãšã³ã²ãŒãžã¡ã³ããå¿èã®å¥åº·ã«çŠç¹ãåœãŠãã©ã€ãã¹ã¿ã€ã«ä»å ¥ã調æ»ããŸããã
- è³ã®å¥åº·ã®æ¹åïŒ2幎éã®ç ç©¶ã®çµæãéäžçãªä»å ¥ãè¡ã£ãã°ã«ãŒãã¯ãã»ã«ããã«ãã°ã«ãŒããšæ¯èŒããŠãè³ã®å¥åº·ã®èгç¹ãã1ã2幎è¥ããšããé«ãææã瀺ããŸãããããã¯ãä»å ¥ã®ã¬ãã«ã«é¢ããããè³ã®å¥åº·ã®äœäžã«åœ±é¿ãäžããããšãå¯èœã§ããããšã蚌æããŸããã
- å®è£ ç ç©¶ãžã®æè³ïŒåäŒã¯ããã®ç¥èŠãå®äžçã§ã®ä»å ¥ãžãšç§»è¡ãããããã4幎éã§4,000äžãã«ãæè³ããå°åã¬ãã«ã§ã®å®è£ ç ç©¶ã远跡調æ»ã»éå§ããŠããŸãã
- å ±å管çã®çµæžç广ïŒèªç¥çã¯ä»ã®NCDsã®ã±ã¢ãè€éã«ããå»çè²»ãé«éš°ãããŸããç±³åœã§ã¯ãæ ¢æ§çŸæ£ãšèªç¥çã®äž¡æ¹ãæã€äººã®å»çè²»ã¯ãæ ¢æ§çŸæ£ã®ã¿ã®å Žåãšæ¯èŒããŠã»ãŒåå¢ããŸããNCDsã®ã¢ãžã§ã³ãã«èªç¥çãå«ããããšã¯ãå ±å管çãå¯èœã«ããç¥èãšæ¿çæ§é ãæ§ç¯ããããã®åŒ·åãªãã³ãšãªããŸãã
4.2. NCDã¢ã©ã€ã¢ã³ã¹CEOïŒé£æºãšã¢ãã¿ãªã³ã°ã®å¿ èŠæ§
ã±ã€ãã£ã»ãžã§ãŒã³CEOã¯ãèªç¥çãNCDs宣èšã«å«ãŸããããšã«å¯ŸããADIãšé¢ä¿è ã®åªåã«ãå€å€§ãªè³èŸããéããŸããã
- 宣èšãå«ãå ·äœçãªå å®¹ïŒæ°ãã宣èšã«ã¯ãç¥çµçŸæ£ïŒã¢ã«ããã€ããŒç ãå«ãïŒã®è² æ ãNCDsãšã¡ã³ã¿ã«ãã«ã¹ã»è³ã®å¥åº·ã®å¯æ¥ãªé¢é£ãã¹ãã£ã°ããšå·®å¥ã®å æã®å¿ èŠæ§ãé«éœ¢å人å£ããããŠ**å€ç æ ïŒmultimorbidityïŒ**ã®èªèãšããã©ã€ããªãã«ã¹ã±ã¢ã¬ãã«ã§ã®èªç¥çãžã®å¯Ÿå¿ã®å¿ èŠæ§ãå ·äœçã«å«ãŸããŠããŸãã
- 次ã®3ã€ã®è¡åã¹ãããïŒå®£èšãå
·äœçãªè¡åã«ç§»ãããã以äžã®é£æºãæ±ããããŸãã
- å ±åã¢ããã«ã·ãŒïŒèªç¥çã³ãã¥ããã£ãšåºç¯ãªNCDã³ãã¥ããã£ããåœå ããã³å°åã¬ãã«ã§å ±åã®æè·æŽ»åãå€§èŠæš¡ãã€è¿ éã«è¡ãããã®è¶³ããããšããŸãã
- å ±åãã£ã³ããŒã³ïŒãã©ã€ããªã»ããªãã³ã·ã§ã³ïŒäžæ¬¡äºé²ïŒã®ã¢ãžã§ã³ããäžå¿ã«å ±åã®æè·æŽ»åãé²ããŸããNCDsã®ãªã¹ã¯å åïŒã¿ãã³èŠå¶ãäžå¥åº·ãªé£äºãã¢ã«ã³ãŒã«åæžãå€§æ°æ±æãªã©ïŒã¯èªç¥çãšå ±éããŠãããWHOã®ããã¹ãã»ãã€ãïŒçšéãã©ãã«è¡šç€ºãããŒã±ãã£ã³ã°èŠå¶ãªã©ïŒã掻çšããŠããªã¹ã¯åæžã®æèåäžãã£ã³ããŒã³ãåœéçãå°åçãåœå ã¬ãã«ã§å±éããæ©äŒããããŸãã
- ã¢ãã¿ãªã³ã°ãšå ±åã®é£æºïŒçŸåšãå€ãã®åœã§NCDèšç»ãšèªç¥çèšç»ãåæãããŠããŸããWHOãæ¥å¹ŽNCDsã®ã°ããŒãã«ã»ã¢ãã¿ãªã³ã°ã»ãã¬ãŒã ã¯ãŒã¯ãæŽæ°ããéã«ãNCDsãšèªç¥çã®è¿œè·¡ã»ç£èŠæ¹æ³ã飿ºãããçµ¶å¥œã®æ©äŒãšæããã¹ãã§ãã
5. ç·æ¬ïŒè°è«ã象城ãã3ã€ã®ããŒã¯ãŒã
ã»ãã·ã§ã³ã®æåŸã«ããããªã¹ãã®å€å²ã«ãããè°è«ãç·æ¬ãã3ã€ã®ããŒã¯ãŒããå ±æãããŸããã
- è€éæ§ïŒComplexityïŒïŒåœäºè ã®ç掻çµéšããæ¿çããžã§ã³ããŒã人暩ã«è³ããŸã§ãããŒãºãåé¡ã®å€æ§æ§ãšè€éãã
- çžä¹å¹æïŒSynergyïŒïŒèªç¥çãšä»ã®NCDã¢ãžã§ã³ããšã®ã€ãªãããªã©ãããç·å¯ãªååãšéåçãªè¡åãéããŠãäºãã®æŽ»åãå¢å¹ ãããæ©äŒã
- åžæïŒHopeïŒïŒéåžžã«ååãã§å®ãããåé²ã®éçã瀺ã建èšçãªäŒè©±ãç¹ã«ãåœäºè ã®ååããªèšŒèšããååœã®å ·äœçãã€å®è¡å¯èœãªèšç»ãããã®ã¢ãžã§ã³ããåé²ãããããã®å®çŸå¯èœãªæ¹æ³ã瀺ããŠããç¹ã
ãã®NCDs宣èšãžã®çµã¿å ¥ãã¯çŽ æŽãããã¹ã¿ãŒãã§ããããã®èšèãšå®£èšãååœã»å°åã¬ãã«ã§ã®å ·äœçãªè¡åãšã³ãããã¡ã³ãã«èœãšã蟌ãã«ã¯ãé¢ä¿è å šå¡ã®ãšãã«ã®ãŒãšã³ãããã¡ã³ããå¿ èŠã§ãããšç· ããããããŸããã